Announcements Trials
Browse Landscape

Status

Completed 7Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 119Neoplasms 100Lung Neoplasms 66Colorectal Neoplasms 60Carcinoma, Hepatocellular 56Carcinoma, Non-Small-Cell Lung 51Prostatic Neoplasms 47Pancreatic Neoplasms 37Uterine Cervical Neoplasms 35Stomach Neoplasms 29Ovarian Neoplasms 28Disease 28Rectal Neoplasms 27Multiple Myeloma 24Leukemia, Myeloid, Acute 21Head and Neck Neoplasms 21Endometrial Neoplasms 21Recurrence 20Esophageal Neoplasms 19Colonic Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Neoplasm Metastasis 17Glioblastoma 17Melanoma 15Lymphoma 15Glioma 15Cholangiocarcinoma 14Urinary Bladder Neoplasms 12Neoplasm, Residual 12Liver Neoplasms 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Critical Illness × Clear all
NCT06674330 2024-11-05

Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness

National Taiwan University Hospital

Not yet recruiting
600 enrolled
Other hematologic neoplasm

Critical Illness, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡